The long-term survival of women with surgical stage II endometrioid type endometrial cancer

Gynecologic Oncology

Volumn 93, Issue 1, 2004, Pages 9-13

  Ayhan, Ali ^a   Taskiran, Cagatay ^a   Celik, Cetin ^a   Yuce, Kunter ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Adjuvant radiotherapy; Failure pattern; Prognostic factors; Radical hysterectomy; Stage II endometrial cancer; Survival

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADULT; AGE; AGED; ARTICLE; ASCITES FLUID CYTOLOGY; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; LYMPHADENECTOMY; MORBIDITY; MULTIVARIATE ANALYSIS; PARAAORTIC LYMPH NODE; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; SALPINGOOOPHORECTOMY; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, ENDOMETRIOID; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 1842530097     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2003.11.018     Document Type: Article

References (30)

1. Heyman J., Reuterwall O., Benner S. The Radiumhemmet experience with radiotherapy in cancer of the corpus of the uterus. Acta Radiol. 22:1941;13-98.
2. Kottmeier H.L. The classification and clinical staging of carcinoma of the uterus and vagina. J. Int. Fed. Gynaecol. 1:1963;83-93.
3. Creasman W.T. Announcement: FIGO stages - 1988 revision. Gynecol. Oncol. 35:1989;125-127.
4. Creasman W., Odicino F., Maisonneuve P., Benedet J., Shepherd J., Sideri M. Carcinoma of the corpus uteri. Annual report on the results of treatment in gynecological cancer. J. Epidemiol. Biostat. 3:1998;35-61.
5. Kaplan E.L., Meier P. Non-parametric estimation for incomplete observations. J. Am. Stat. Assoc. 53:1958;457-481.
6. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep. 50:1966;163-170.
7. Cox D.R. Regression models and life tables (with discussion). J. R. Stat. Soc. 34:1972;187-202.
8. Cornelison T.L., Trimble E.L., Kosary C.L. SEER data, corpus uteri cancer: treatment trends versus survival for FIGO stage II, 1988-1994. Gynecol. Oncol. 74:1999;350-355.
9. Morrow C.P., Bundy B.N., Kurman R.J., Creasman W.T., Heller P., Homesley H.D.et al. Relationship between surgical pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group Study. Gynecol. Oncol. 40:1991;55-65.
10. Fanning J., Nanavati P.J., Hilgers R.D. Surgical staging and high dose rate brachytherapy for endometrial cancer: limiting external radiotherapy to node-positive tumors. Obstet. Gynecol. 87:1996;1041-1044.
11. Kilgore L.C., Partridge E.E., Alvarez R.D., Maxwell A.J., Shingleton H.M., Noojin F. IIIet al. Adenocarcinoma of the endometrium-survival comparisons of patients with and without pelvic node sampling. Gynecol. Oncol. 56:1995;29-33.
12. Fanning J., Firestein S. Prospective evaluation of the morbidity of complete lymphadenectomy in endometrial cancer. Int. J. Gynecol. Cancer. 8:1998;270-273.
13. Fanning J. Treatment for early endometrial cancer: cost-effective analysis. J. Reprod. Med. 44:1999;719-723.
14. Blake P., Lodge N., A'hern R.P. An audit of outcome of adjuvant post-operative radiotherapy for 52 women with stage II carcinoma of the endometrium. Br. J. Radiol. 73:2000;987-993.
15. Calvin D.P., Connell P.P., Rotmensch J., Waggoner S., Mundt A.J. Surgery and postoperative radiation therapy in stage II endometrial carcinoma. Am. J. Clin. Oncol. 22(4):1999;338-343.
16. Roberts J.A., Brunetto V.L., Keys H.M., Zaino R., Spirtos N.M., Bloss J.D.et al. A phase III randomized study of surgery vs. surgery plus adjunctive radiation therapy in intermediate risk endometrial adenocarcinoma (GOG 99). Presented at the 29th annual meeting of the Society of Gynecologic Oncologists. Gynecol. Oncol. 68:1998;135. [abstract].
17. Feltmate C.M., Duska L.R., Chang Y., Cynthia E.F., Nikrui N., Kiggundu E.et al. Predictors of recurrence in surgical stage II endometrial adenocarcinoma. Gynecol. Oncol. 73:1999;407-411.
18. Ng T.Y., Nicklin J.L., Perrin L.C., Cheuk R., Crandon A.J. Postoperative vaginal vault brachytherapy for node-negative stage II (occult) endometrial carcinoma. Gynecol. Oncol. 81:2001;193-195.
19. Eltabbakh G.H., Moore A.D. Survival of women with surgical stage II endometrial cancer. Gynecol. Oncol. 74:1999;80-85.
20. Elia G., Garfinkel D.A., Goldberg G.L., Davidson S., Runowicz C.D. Surgical management of patients with endometrial cancer and cervical involvement. Eur. J. Gynaecol. Oncol. 16:1995;169-173.
21. Tamura H., Nakai Y., Nagano T., Ohara A., Shibamoto T., Nakayama T.et al. Treatment and prognosis of pT2 endometrial carcinoma. Nippon Sanka Fujinka Gakkai Zasshi (Acta Obstet. Gynecol. Jap.). 43:1991;315-320.
22. Boente M.P., Edgardo L.Y., McIntosh D.G., Grendys E.C., Orandi Y.A., Davies S.et al. Prognostic factors and long-term survival in endometrial adenocarcinoma with cervical involvement. Gynecol. Oncol. 51:1993;316-322.
23. Greven K.M., Corn B.W., Case D., Purser P., Lanciano R.M. Which prognostic factors influence the outcome of patients with surgically staged endometrial cancer treated with adjuvant radiation? Int. J. Radiol. Biol. Phys. 39:1997;413-418.
24. Deschamps P., Calais G., Moire C., Bertrand P., Castiel M., Floch O.L.et al. Predictors of distant recurrence in clinical stage I or II endometrial carcinoma treated by combination surgical and radiation therapy. Gynecol. Oncol. 64:1997;54-58.
25. Lanciano R.M., Curran W.J., Greven K.M., Fanning J., Stafford P., Randall M.E.et al. Influence of grade, histologic subtype, and timing of radiotherapy on outcome among patients with stage II carcinoma of the endometrium. Gynecol. Oncol. 39:1990;368-373.
26. Reisenger S.A., Staros E.B., Mohiuddin M. Survival and failure analysis in stage II endometrial cancer using the revised 1988 FIGO staging system. Int. J. Radiol. Biol. Phys. 21:1991;1027-1032.
27. Andersen E.S. Stage II endometrial carcinoma: prognostic factors and the results of treatment. Gynecol. Oncol. 38:1990;220-223.
28. Fanning J., Alvarez P.M., Tsukada Y., Piver M.S. Prognostic significance of the extent of cervical involvement by endometrial cancer. Gynecol. Oncol. 40:1991;47.
29. Kadar N., Malfetano J.H., Homesley H.D. Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus: implications for therapy. Obstet. Gynecol. 80:1992;655-659.
30. Lanciano R.M., Corn B.W., Schultz D.J., Kramer C.A., Rosenblum N., Hogan W.M. Justification for a surgical staging system in endometrial carcinoma. Radiother. Oncol. 28:1993;189-196.